Open Access Open Access  Restricted Access Subscription Access

Diosgenin as a Novel Therapeutic Natural Product for Various Diseases: An Overview


Affiliations
1 Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris - 643001, Tamil Nadu, India
 

Diosgenin (DG) is a saponin glycoside and an active constituent generally present in medicinal plants like Rhizoma polgonita, Trigonella foenum, Dioscorea villosa and Dioscorea rhizome. It is also the starting material for the biosynthesis of steroidal hormones. DG has also been reported as a multipurpose drug aiding in the treatment of various cardiovascular, neurological diseases as well as as malignancies, osteoporosis, diabetes, and atherosclerosis. The underlying mechanisms of DG contributing towards potential therapeutic ability is to suppress the expression of oncogenic genes, preventing the formation of free radicals and thereby resulting in neuroprotection etc. However, the use of DG is restricted due to its limited pharmacokinetic properties such as poor aqueous solubility, poor bioavailability, and quicker biotransformation into its metabolites. Hence, in this study we have briefed the current therapeutic approaches of DG and its derivatives alongside to its medicinal chemistry and its physicochemical, pharmacological & toxicological properties.

Keywords

Biosynthesis, Diosgenin, Phytochemical, Saponin Glycoside, Steroidal Hormone.
Font Size

User

Notifications
JOURNAL COVERS
  

  • Cai B, Zhang Y, Wang Z, Xu D, Jia Y, Guan Y, Liao A, Liu G, Chun C, Li J. Therapeutic potential of diosgenin and its major derivatives against neurological diseases: Recent advances. Oxid Med Cell Longev. 2020; 3153082. https://doi.org/10.1155/2020/3153082
  • Tohda C, Urano T, Umezaki M, Nemere I, Kuboyama T. Diosgenin is an exogenous activator of 1,25D3-MARRS/Pdia3/ERp57 and improves Alzheimer’s disease pathologies in 5XFAD mice. Sci Rep. 2012; 2:535. https://doi.org/10.1038/srep00535
  • Ondeykal JG, Herath KB, Jayasuriya H, Polishook JD, Bills GF, Dombrowski AW, Mojena M, Koch G, DiSalvo J, DeMartino J, Guan Z, Nanakorn W, Morenberg CM, Balick MJ, Stevenson DW, Slattery M, Borris RP, Singh SB. Discovery of structurally diverse natural product antagonists of chemokine receptor CXCR3. Mol Divers. 2005; 9(1-3):123-9. https://doi.org/10.1007/s11030-005-1296-8
  • Shishodia S, Aggarwal BB. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, IκB kinase activation and NF-κB-regulated gene expression. Oncogene. 2006; 25(10):1463-1473. https://doi.org/10.1038/ sj.onc.1209194
  • Li B, Xu P, Wu S, Jiang Z, Huang Z, Li Q, Chen D. Diosgenin attenuates lipopolysaccharide-induced parkinson’s disease by inhibiting the TLR/NF- κB Pathway. J Alzheimers Dis. 2018; 64(3):943-55. https://doi.org/10.3233/JAD-180330
  • Tohda C, Lee Y-A, Goto Y, Nemere I. Diosgenininduced cognitive enhancement in normal mice is mediated by 1,25D3-MARRS. Sci Rep. 2013; 3(1):3395.https://doi.org/10.1038/srep03395
  • Cheng SM, Ho YJ, Yu SH, Liu YF, Lin YY, Huang CY, Ou HC, Huang HL, Lee SD. Anti-Apop7. totic effects of diosgenin in D-galactose-induced aging brain. Am J Chin Med. 2020; 48(2):391-406. https://doi. org/10.1142/S0192415X20500202
  • Wu S, Zhao M, Sun Y, Xie M, Le K, Xu M, Huang C. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimodinduced murine model. Life Sci. 2020; 241:117115. https://doi.org/10.1016/j.lfs.2019.117115
  • Gong G, Qin Y, Huang W. Anti-thrombosis effect of diosgenin extract from Dioscorea zingiberensis C.H. Wright In vitro and In vivo. Phytomedicine. 2011; 18(6):458-463. https://doi.org/10.1016/j.phymed.2010.08.015
  • Chen CT, Wang ZH, Hsu CC, Lin HH and Chen JH. In vivo protective effects of diosgenin against doxorubicin-induced cardiotoxicity. Nutrients. 2015; 7(6):4938-4954. https://doi.org/10.3390/nu7064938
  • Manivannan J, Shanthakumar J, Silambarasan T, Balamurugan E, Raja B. Diosgenin, a steroidal saponin, prevents hypertension, cardiac remodeling and oxidative stress in adenine induced chronic renal failure rats. RSC Adv. 2015; 5(25):19337-19344. https:// doi.org/10.1039/C4RA13188F
  • Zhang J, Xie JJ, Zhou SJ, Chen J, Hu Q, Pu JX, Lu JL. 2019 Diosgenin inhibits the expression of NEDD4 in prostate cancer cells. Am J Transl Res. 2019; 11(6): 3461-3471.
  • Yu H, Liu Y, Niu C, Cheng Y. 2018 Diosgenin increased DDX3 expression in hepatocellular carcinoma. Am J Transl Res. 2018; 10(11): 3590-3599.
  • Chiang CT, Way TD, Tsai SJ, Lin JK. Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation. FEBS Lett. 2007; 581(30):5735-5742. https://doi.org/10.1016/j.febslet.2007.11.021
  • Kim DH, Hong BN, Le HT, Hong HN, Lim CW, Park KH, Kim TW, Kang TH. Small molecular weight PEGylation of diosgenin in an In vivo animal study for diabetic auditory impairment treatment. Bioorg Med Chem Lett. 2012; 22(14):4609-4612. https://doi. org/10.1016/j.bmcl.2012.05.094
  • Yi T, Fan LL, Chen HL, Zhu GY, Suen HM, Tang YN, Zhu L, Chu C, Zhao ZZ, Chen HB. 2014 Comparative analysis of diosgenin in Dioscorea species and related medicinal plants by UPLC-DAD-MS. BMC Biochem. 2014; 15:19. https://doi.org/10.1186/1471-2091- 15-19
  • Al-Habori M, Raman A, Lawrence MJ, Skett P. In vitro effect of fenugreek extracts on intestinal sodium-dependent glucose uptake and hepatic glycogen phosphorylase A. Int J Exp Diabetes Res. 2001; 2(2):91-9. https://doi.org/10.1155/EDR.2001.91
  • Ur Rahman S, Adhikari A, Ismail M, Raza Shah M, Khurram M, Shahid M, Ali F, Haseeb A, Akbar F, Iriti M. Beneficial effects of Trillium govanianum rhizomes in pain and inflammation. Molecules. 2016; 21(8):1095. https://doi.org/10.3390/molecules21081095
  • Rothrock JW, Hammes P, Mcaleer WJ. Isolation of diosgenin by acid hydrolysis of saponin. Ind Eng Chem. 1957; 49:186-188. https://doi.org/10.1021/ ie50566a025
  • Xu M, Huo XK, Tian XG, Dong PP, Wang C, Huang SS, Zhang BJ, Zhang HL, Deng S, Ma XC. 2015 Microbial transformation of diosgenin by Cunninghamella blakesleana AS 3.970 and potential inhibitory effects on P-glycoprotein of its metabolites. RSC Adv. 2015; 5(95):78081-78089. https://doi.org/10.1039/C5RA12253H
  • PubChem. Diosgenin (internet). 2021. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/99474
  • Indrayanto G, Utami W, Santosa MH, Syahrani A. Diosgenin. In: Brittain HG, editor. Analytical profiles of drug substances and excipients [Internet]. Academic Press; [cited 2021 Dec 7]. 1994; 99-124. Available from: https://www.sciencedirect. com/science/article/pii/S0099542808606012 https://doi.org/10.1016/S0099-5428(08)60601-2
  • Görög S. Advances in the analysis of steroid hormone drugs in pharmaceuticals and environmental samples (2004-2010). J Pharm Biomed Anal. 2011; 55(4):728- 743. https://doi.org/10.1016/j.jpba.2010.11.011
  • Chen B, Zhou S, Zhan Y, Ke J, Wang K, Liang Q, Hou Y, Zhu P, Ao W, Wei X, Xiao J. Dioscin inhibits the invasion and migration of hepatocellular carcinoma HepG2 cells by reversing TGF-β1-induced epithelial-mesenchymal transition. Molecules. 2019; 24(12):2222. https://doi.org/10.3390/molecules24122222
  • Lim WC, Kim H, Kim YJ, Choi KC, Lee IH, Lee KH, Kim MK, Ko H. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion. Bioorg Med Chem Lett. 2017; 27(15):3342-3348. https://doi. org/10.1016/j.bmcl.2017.06.014
  • Tao X, Yin L, Xu L, Peng J. Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections. Pharmacol Res. 2018; 137:259-269. https://doi. org/10.1016/j.phrs.2018.09.022
  • Chaudhary S, Chikara SK, Sharma MC, Chaudhary A, Alam Syed B, Chaudhary PS, Mehta A, Patel M, Ghosh A, Iriti M. Elicitation of diosgenin production in Trigonella foenum- graecum (Fenugreek) Seedlings by methyl jasmonate. Int J Mol Sci. 2015;. 16(12):29889-29899. https://doi.org/10.3390/ijms161226208
  • Christ B, Xu C, Xu M, Li FS, Wada N, Mitchell AJ, Han XL, Wen ML, Fujita M, Weng JK. Repeated evolution of cytochrome P450-mediated spiroketal steroid biosynthesis in plants. Nat Commun. 2019; 10:3206. https://doi.org/10.1038/s41467-019-11286-7
  • Cheng J, Chen J, Liu X, Li X, Zhang W, Dai Z, Lu L, Zhou X, Cai J, Zhang X, Jiang H, Ma Y, et al. The origin and evolution of the diosgenin biosynthetic pathway in yam. Plant Commun. 2021; 2(1):100079. https://doi.org/10.1016/j.xplc.2020.100079
  • Manda VK, Avula B, Ali Z, Wong YH, Smillie TJ, Khan IA, Khan SI. Characterization of In vitro ADME properties of diosgenin and dioscin from Dioscorea villosa. Planta Med. 2013; 79(15):1421-1428. https://doi.org/10.1055/s-0033-1350699
  • Okawara M, Tokudome Y, Todo H, Sugibayashi K, Hashimoto F. Enhancement of diosgenin distribution in the skin by cyclodextrin complexation following oral administration. Biol Pharm Bull. 2013; 36(1):36- 40. https://doi.org/10.1248/bpb.b12-00467
  • Okawara M, Hashimoto F, Todo H, Sugibayashi K, Tokudome Y. Effect of liquid crystals with cyclodextrin on the bioavailability of a poorly water-soluble compound, diosgenin, after its oral administration to rats. Int J Pharm. 2014; 472(1-2):257-261. https://doi. org/10.1016/j.ijpharm.2014.06.032
  • Singh M, Hamid AA, Maurya AK, Prakash O, Khan F, Kumar A, Aiyelaagbe OO, Negi AS, Bawankule DU. Synthesis of diosgenin analogues as potential anti-inflammatory agents. J Steroid Biochem Mol Biol. 2014; 143:323-333. https://doi.org/10.1016/j. jsbmb.2014.04.006
  • Mohamadi N, Sharififar F, Ansari M, Pournamdari M, Rezaei M, Hassanabadi N. Pharmacokinetic profile of diosgenin and trigonelline following intravenous and oral administration of fenugreek seed extract and pure compound in rabbit. J Asian Nat Prod Res. 2021; 23(5):466-477. https://doi.org/10.1080/10286020.2020.1769609
  • Gao M, Chen L, Yu H, Sun Q, Kou J, Yu B. Diosgenin down-regulates NF-κB p65/p50 and p38MAPK pathways and attenuates acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol. 2013; 15(2):240-245. https://doi.org/10.1016/j. intimp.2012.11.019
  • Cai B, Seong K-J, Bae S-W, Chun C, Kim W-J, Jung J-Y. A synthetic diosgenin primary amine derivative attenuates LPS-stimulated inflammation via inhibition of NF-κB and JNK MAPK signaling in microglial BV2 cells. Int Immunopharmacol. 2018; 61:204-214. https://doi.org/10.1016/j.intimp.2018.05.021
  • Gouras GK, Olsson TT, Hansson O. β-Amyloid peptides and amyloid plaques in Alzheimer’s disease. Neurother J Am Soc Exp Neurother. 2015; 12(1):3-11. https://doi.org/10.1007/s13311-014-0313-y
  • Lecanu L, Rammouz G, McCourty A, Sidahmed EK, Greeson J, Papadopoulos V. Caprospinol reduces amyloid deposits and improves cognitive function in a rat model of Alzheimer’s disease. Neuroscience. 2010; 165(2):427-435. https://doi.org/10.1016/j.neuroscience. 2009.10.033
  • Yang X, Tohda C. 2018 Diosgenin restores Aβ-induced axonal degeneration by reducing the expression of heat shock cognate 70 (HSC70). Sci Rep. 2018; 8(1): 11707. https://doi.org/10.1038/s41598-018-30102-8
  • Huang Y, Huang W, Yang G, Wang R, Ma L. Design and synthesis of novel diosgenin- triazole hybrids targeting inflammation as potential neuroprotective agents. Bioorg Med Chem Lett. 2021; 43:128092. .https://doi.org/10.1016/j.bmcl.2021.128092
  • Koh EK, Yun WB, Kim JE, Song SH, Sung JE, Lee HA, Seo EJ, Jee SW, Bae CJ, Hwang DY. Beneficial effect of diosgenin as a stimulator of NGF on the brain with neuronal damage induced by Aβ-42 accumulation and neurotoxicant injection. Lab Anim Res. 2016; 32(2):105-115. https://doi.org/10.5625/lar.2016.32.2.105
  • Tohda C, Yang X, Matsui M, Inada Y, Kadomoto E, Nakada S, Watari H, Shibahara N. Diosgenin-richyam extract enhances cognitive function: A placebocontrolled, randomized, double-blind, crossover study of healthy adults. Nutrients. 2017; 9(10):1160. https://doi.org/10.3390/nu9101160
  • Zhou LC, Liang YF, Huang Y, Yang GX, Zheng LL, Sun JM, Li Y, Zhu FL, Qian HW, Wang R, Ma L. 2021 Design, synthesis, and biological evaluation of diosgenin-indole derivatives as dualfunctional agents for the treatment of Alzheimer’s disease. Eur J Med Chem. 2021; 219:113426. https://doi.org/10.1016/j.ejmech.2021.113426
  • Karimi Askarani H, Iraji A, Rastegari A, Abbas Bukhari SN, Firuzi O, Akbarzadeh T, Saeedi M. Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl- chromenone derivatives with potential use in Alzheimer’s disease. BMC Chem. 2020; 14(1):64. https://doi.org/10.1186/s13065-020-00715-0
  • Zheng H, Wei Z, Xin G, Ji C, Wen L, Xia Q, Niu H, Huang W. 2016 Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo. Bioorg Med Chem Lett. 2016; 26(14):3364-3369. https://doi.org/10.1016/j.bmcl.2016.05.032
  • Xue Y, Lin J, Zhang H, Xiao F, Li W, Huang N. 2021 Anti-cardiovascular effects of diosgenin and its related derivatives. MEDS Clinical Medicine. 2021; 2: 10-14.
  • Li X, Liu S, Qu L, Chen Y, Yuan C, Qin A, Liang J, Huang Q, Jiang M, Zou W. Dioscin and diosgenin: Insights into their potential protective effects in cardiac diseases. J Ethnopharmacol. 2021; 274:114018. https://doi.org/10.1016/j.jep.2021.114018
  • Ghosh S, More P, Derle A, Patil AB, Markad P, Asok A, Kumbhar N, Shaikh ML, Ramanamurthy B, Shinde VS, Dhavale DD, Chopade BA. Diosgenin from Dioscorea bulbifera: Novel hit for treatment of type II Diabetes mellitus with inhibitory activity against α-Amylase and α-Glucosidase. PLoS One. 2014; 9(9):e106039. https://doi.org/10.1371/journal. pone.0106039
  • McAnuff MA, Harding WW, Omoruyi FO, Jacobs H, Morrison EY, Asemota HN. Hypoglycemic effects of steroidal sapogenins isolated from Jamaican bitter yam, Dioscorea polygonoides. Food Chem Toxicol. 2005; 43(11):1667-1672. https://doi.org/10.1016/j. fct.2005.05.008
  • Fang K, Dong H, Jiang S, Li F, Wang D, Yang D, Gong J, Huang W, Lu F. Diosgenin and 5-methoxypsoralen ameliorate insulin resistance through ER-α/PI3K/ Akt-signaling pathways in HepG2 Cells. Evid Based Complement Alternat Med. 2016; 1-11. https://doi. org/10.1155/2016/7493694
  • Sato K, Fujita S, Iemitsu M. Acute administration of diosgenin or dioscorea improves hyperglycemia with increases muscular steroidogenesis in STZinduced type 1 diabetic rats. J Steroid Biochem Mol Biol. 2014; 143:152-159. https://doi.org/10.1016/j. jsbmb.2014.02.020
  • Kiss R, Pesti-Asbóth G, Szarvas MM, Stündl L, Cziáky Z, Hegedűs C, Kovács D, Badale A, Máthé E, Szilvássy Z, Remenyik J. Diosgenin and its fenugreek based biological matrix affect insulin resistance and anabolic hormones in a rat based insulin resistance model. BioMed Res Int. 2019; 1-13. https://doi.org/10.1155/2019/7213913
  • Kalailingam P, Kannaian B, Tamilmani E, Kaliaperumal R. Efficacy of natural diosgenin on cardiovascular risk, insulin secretion, and beta cells in Streptozotocin (STZ)-induced diabetic rats. Phytomedicine. 2014; 21(10):1154-1161. https://doi. org/10.1016/j.phymed.2014.04.005
  • Tharaheswari M, Jayachandra Reddy N, Kumar R, Varshney KC, Kannan M, Sudha Rani S. Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats. Mol Cell Biochem. 2014; 396(1-2):161-174. https://doi.org/10.1007/s11010-014-2152-x
  • Hao S, Xu R, Li D, Zhu Z, Wang T, Liu K. Attenuation of streptozotocin-induced lipid profile anomalies in the heart, brain, and mRNA expression of HMG-CoA reductase by diosgenin in rats. Cell Biochem Biophys. 2015; 72(3):741-749. https://doi.org/10.1007/s12013- 015-0525-8
  • Sethi G, Shanmugam MK, Warrier S, Merarchi M, Arfuso F, Kumar AP, Bishayee A. Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review. Nutrients. 2018; 10(5):645. https://doi.org/10.3390/nu10050645
  • Raju J, Patlolla JMR, Swamy MV, Rao CV. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomark Prev. 2004; 13(8):1392-1398. https://doi.org/10.1158/1055-9965.1392.13.8
  • Malisetty VS, Patlolla JMR, Raju J, Marcus LA, Choi C-I, Rao CV. Chemoprevention of colon cancer by diosgenin, a steroidal saponin constituent of fenugreek. Cancer Res. 2005; 65(9):580.
  • Miyoshi N, Nagasawa T, Mabuchi R, Yasui Y, Wakabayashi K, Tanaka T, Ohshima H. Chemoprevention of azoxymethane/dextran sodium sulfate-induced mouse colon carcinogenesis byfreeze-dried yam sanyaku and its constituent diosgenin. Cancer Prev Res (Phila). 2011; 4(6):924-934. https://doi.org/10.1158/1940-6207.CAPR-10-0279
  • Srinivasan S, Koduru S, Kumar R, Venguswamy G, Kyprianou N, Damodaran C. Diosgenin targets Aktmediated prosurvival signaling in human breast cancer cells. Int J Cancer. 2009; 125(4):961-967. https://doi.org/10.1002/ijc.24419
  • Yan LL, Zhang YJ, Gao WY, Man SL, Wang Y. 2009 In vitro and In vivo anticancer activity of steroid saponins of Paris Polyphylla var. yunnanensis. Exp Oncol. 2009; 31(1): 27-32.
  • Jagadeesan J, Langeswaran K, Gowthamkumar S, Balasubramanian MP. Diosgenin exhibits beneficial efficiency on human mammary carcinoma cell line MCF-7 and against N- Nitroso-N-Methylurea (NMU) induced experimental mammary carcinoma. Biomed Prev Nutr. 2013; 3(4):381-388. https://doi.org/10.1016/j.bionut.2013.06.009
  • Das S, Dey KK, Dey G, Pal I, Majumder A, MaitiChoudhury S, kundu SC, Mandal M. Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS One. 2012; 7(10):e46641. https://doi.org/10.1371/journal.pone.0046641
  • Sánchez-Sánchez L, Hernández-Linares MG, Escobar ML, López-Muñoz H, Zenteno E, Fernández-Herrera MA, Guerrero-Luna G, Carrasco-Carballo A, Sandoval-Ramírez J. Antiproliferative, cytotoxic, and apoptotic activity of steroidal oximes in cervicouterine cell lines. Molecules. 2016; 21(11):1533. https:// doi.org/10.3390/molecules21111533
  • Masood-ur-Rahman, Mohammad Y, Fazili KM, Bhat KA Ara T. Synthesis and biological evaluation of novel 3-O-tethered triazoles of diosgenin as potent antiproliferative agents. Steroids. 2017; 118:1-8. https://doi. org/10.1016/j.steroids.2016.11.003
  • Liu C, Xie F, Zhao GD, Wang DF, Lou HX, Liu ZP. Synthetic studies towards 1α- hydroxysolasodine from diosgenin and the unexpected tetrahydrofuran ring opening in the Birch reduction process. Steroids. 2015; 104:214-219. https://doi.org/10.1016/j.steroids. 2015.10.006
  • Hamid AA, Kaushal T, Ashraf R, Singh A, Chand Gupta A, Prakash O, Sarkar J, Chanda D, Bawankule DU, Khan F, Shanker K, Aiyelaagbe OO, Negi AS. (22β,25R)-3β-Hydroxy-spirost-5-en-7-iminoxyheptanoic acid exhibits anti-prostate cancer activity through caspase pathway. Steroids. 2017; 119:43-52. https://doi.org/10.1016/j.steroids.2017.01.001
  • Ghosh S, More P, Derle A, Kitture R, Kale T, Gorain M, Avasthi A, Markad P, Kundu GC, Kale S, Dhavale DD, Bellare J, Chopade BA. Diosgenin functionalized iron oxide nanoparticles as novel nanomaterial against breast cancer. J Nanosci Nanotechnol. 2015; 15(12):9464-9472. https://doi.org/10.1166/jnn.2015.11704
  • Yang GX, Huang Y, Zheng LL, Zhang L, Su L, Wu YH, Li J, Zhou LC, Huang J, Tang Y, Wang , Ma L. Design, synthesis and evaluation of diosgenin carbamate derivatives as multitarget anti-Alzheimer’s disease agents. Eur J Med Chem. 2020; 187:111913. https:// doi.org/10.1016/j.ejmech.2019.111913
  • Xin G, Wang Y, Guo X, Huang B, Du D, He S, Zhang R, Xing Z, Zhao H, Chen Q, Huang W, He Y. Synthesis of diosgenin-ibuprofen derivatives and their activities against insulin- dependant Diabetes mellitus. 2013. https://doi.org/10.1248/cpb.c12-01024
  • Myszka H, Sokołowska P, Cieślińska A, Nowacki A, Jaśkiewicz M, Kamysz W, Liberek B. Diosgenyl 2-amino-2-deoxy-β-D-galactopyranoside: synthesis, derivatives and antimicrobial activity. Beilstein J Org Chem. 2017; 13(1):2310-2315. https://doi. org/10.3762/bjoc.13.227
  • Cai D, Qi J, Yang Y, Zhang W, Zhou F, Jia X, Guo W, Huang X, Gao F, Chen H, Li T, Li G, Wang P, Zhang Y, Lei H. Design, synthesis and biological evaluation of diosgenin- amino acid derivatives with dual functions of neuroprotection and angiogenesis. Mol Basel Switz. 2019; 24(22):4025. https://doi.org/10.3390/ molecules24224025
  • Ma L, Zhang J, Wang X, Yang J, Guo L, Wang X, Song B, Dong W, Wang W. Design and synthesis of diosgenin derivatives as apoptosis inducers through mitochondria-related pathways. Eur J Med Chem. 2021; 217:113361. https://doi.org/10.1016/j. ejmech.2021.113361
  • Zhang J, Wang X, Yang J, Guo L, Wang X, Song B, Dong W, Wang W. 2020 Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation. Eur J Med Chem. 2020; 186:111897. https://doi.org/10.1016/j.ejmech.2019.111897
  • Michalak O, Krzeczyński P, Cieślak M, Cmoch P, Cybulski M, Królewska-Golińska K, Kaźmierczak- Barańska J, Trzaskowski B, Ostrowska K. Synthesis and anti-tumour, immunomodulating activity of diosgenin and tigogenin conjugates. J Steroid Biochem Mol Biol. 2020; 198:105573. https://doi.org/10.1016/j.jsbmb.2019.105573
  • Shen Y, Wen L, Zhang R, Wei Z, Shi N, Xiong Q, Xia Q, Xing Z, Zeng Z, Niu H, Huang W. Dihydrodiosgenin protects against experimental acute pancreatitis and associated lung injury throughmitochondrial protection and PI3Kγ/Akt inhibition. Br J Pharmacol. 2018; 175(10):1621-1636. https://doi.org/10.1111/bph.14169
  • Cayen MN, Ferdinandi ES, Greselin E, Dvornik D. Studies on the disposition of diosgenin in rats, dogs, monkeys and man. Atherosclerosis. 1979; 33(1):71-87. https://doi.org/10.1016/0021-9150(79)90199-055. 78. Qin Y, Wu X, Huang W, Gong G, Li D, He Y and Zhao Y. Acute toxicity and sub-chronic toxicity of steroidal saponins from Dioscorea zingiberensis C.H.Wright in rodents. J Ethnopharmacol. 2009; 126(3):543-550. https://doi.org/10.1016/j.jep.2009.08.047
  • Qin Y, Wu X, Huang W, Gong G, Li D, He Y, Zhao Y. Acute toxicity and sub-chronic toxicity of steroidal saponins from Dioscorea zingiberensis C.H.Wright in rodents. J Ethnopharmacol. 2009; 126(3):543-550. https://doi.org/10.1016/j.jep.2009.08.047
  • Lima CM, Lima AK, Melo MG, Serafini MR, Oliveira DL, de Almeida EB, Barreto RS, Nogueira PC, Moraes VR, Oliveira ER, de Albuquerque RL Jr, Quintans- Júnior LJ, Araújo AA. Bioassay-guided evaluation of Dioscorea villosa - an acute and subchronic toxicity, antinociceptive and anti-inflammatory approach. BMC Complement Altern Med. 2013; 13(1):195. https://doi.org/10.1186/1472-6882-13-195
  • Wojcikowski K, Wohlmuth H, Johnson DW, Gobe G. Dioscorea villosa (wild yam) induces chronic kidney injury via pro-fibrotic pathways. Food Chem Toxicol. 2008; 46(9):3122-3131. https://doi.org/10.1016/j.fct.2008.06.090
  • Cruz MS, Navoni JA, da Costa Xavier LA, Madalena Rocha Silva Teles M, Barbosa-Filho JM, Almeida- Lima J, de Oliveira Rocha HA, do Amaral VS. Diosgenin induces genotoxic and mutagenic effects on HepG2 cells. Food Chem Toxicol. 2018; 120:98-103. https://doi.org/10.1016/j.fct.2018.07.011

Abstract Views: 148

PDF Views: 77




  • Diosgenin as a Novel Therapeutic Natural Product for Various Diseases: An Overview

Abstract Views: 148  |  PDF Views: 77

Authors

Sheik Mohammed
Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris - 643001, Tamil Nadu, India
Gaddam Narasimha Rao
Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris - 643001, Tamil Nadu, India
Chintha Narendar
Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris - 643001, Tamil Nadu, India
Jeyaram Bharathi
Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris - 643001, Tamil Nadu, India
Antony Justin
Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris - 643001, Tamil Nadu, India

Abstract


Diosgenin (DG) is a saponin glycoside and an active constituent generally present in medicinal plants like Rhizoma polgonita, Trigonella foenum, Dioscorea villosa and Dioscorea rhizome. It is also the starting material for the biosynthesis of steroidal hormones. DG has also been reported as a multipurpose drug aiding in the treatment of various cardiovascular, neurological diseases as well as as malignancies, osteoporosis, diabetes, and atherosclerosis. The underlying mechanisms of DG contributing towards potential therapeutic ability is to suppress the expression of oncogenic genes, preventing the formation of free radicals and thereby resulting in neuroprotection etc. However, the use of DG is restricted due to its limited pharmacokinetic properties such as poor aqueous solubility, poor bioavailability, and quicker biotransformation into its metabolites. Hence, in this study we have briefed the current therapeutic approaches of DG and its derivatives alongside to its medicinal chemistry and its physicochemical, pharmacological & toxicological properties.

Keywords


Biosynthesis, Diosgenin, Phytochemical, Saponin Glycoside, Steroidal Hormone.

References





DOI: https://doi.org/10.18311/jnr%2F2023%2F30378